Skip to content
Bristows
Expertise
Core sectors
Life sciences
Technology
Brands
Litigation & dispute resolution (Archive)
Advertising & marketing
Arbitration
Artificial intelligence
Charities & not-for-profit
Commercial & IP transactions
Competition advice & investigations
Competition litigation
Corporate & financing
Cyber & data breaches
Transactions
Data protection & privacy
Defamation & privacy disputes
Employment & immigration
Freedom to operate
IT & digital projects
IT disputes
Life sciences regulatory
Litigation & dispute resolution
Merger control
Regulatory & advisory
Outsourcing
Patent litigation
Real estate
SEP/FRAND disputes
Tax
Telecommunications
Trade mark, designs & copyright disputes
Trade mark & design portfolio management
UPC
Viewpoint
Articles
Events
News
Podcasts
Publications
People
Careers
Trainees
Apprentices
Current opportunities
Diversity, Equality & Inclusion
Life at Bristows
About us
Our values
A reputation for firsts
International reach
Awards
Corporate responsibility
Alumni
Compliance information
GDPR
Contact
Search...
toggle mobile menu
Home
Healthtech articles
Healthtech
Related commentary
Related articles
A new model clinical trial agreement – the good, the bad and (in its current form) the ugly
26.06.2024
Charlie French quoted in the Financial Times and Law360
29.04.2024
UK MDR: further delays, unexpected developments?
23.01.2024
View more